Korro Bio
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Korro Bio and other ETFs, options, and stocks.About KRRO
Korro Bio, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of a new class of genetic medicines based on editing RNA. The company was founded by Nessan Bermingham, Jean-Francois B.
CEORam Aiyar
CEORam Aiyar
Employees104
Employees104
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2018
Founded2018
Employees104
Employees104
KRRO Key Statistics
Market cap64.04M
Market cap64.04M
Price-Earnings ratio-0.72
Price-Earnings ratio-0.72
Dividend yield—
Dividend yield—
Average volume525.76K
Average volume525.76K
High today$7.04
High today$7.04
Low today$5.92
Low today$5.92
Open price$6.02
Open price$6.02
Volume962.27K
Volume962.27K
52 Week high$55.89
52 Week high$55.89
52 Week low$5.20
52 Week low$5.20
Stock Snapshot
With a market cap of 64.04M, Korro Bio(KRRO) trades at $6.70. The stock has a price-to-earnings ratio of -0.72.
On 2025-12-04, Korro Bio(KRRO) stock traded between a low of $5.92 and a high of $7.04. Shares are currently priced at $6.70, which is +13.2% above the low and -4.8% below the high.
The Korro Bio(KRRO)'s current trading volume is 962.27K, compared to an average daily volume of 525.76K.
During the past year, Korro Bio(KRRO) stock moved between $5.20 at its lowest and $55.89 at its peak.
During the past year, Korro Bio(KRRO) stock moved between $5.20 at its lowest and $55.89 at its peak.
Analyst ratings
100%
of 10 ratingsBuy
0%
Hold
100%
Sell
0%
People also own
Based on the portfolios of people who own KRRO. This list is generated using Robinhood data, and it’s not a recommendation.